Avinger +24% on FDA clearance for Pantheris SV device

Apr. 10, 2019 8:59 AM ETAvinger, Inc. (AVGR)By: Mamta Mayani, SA News Editor28 Comments
  • The FDA grants 510(k) clearance to Avinger's (NASDAQ:AVGR) Pantheris SV (Small Vessel) image-guided atherectomy system.
  • Pantheris SV is indicated for the diagnosis and treatment of Peripheral Artery Disease in small vessels (2 to 4 millimeters in diameter).
  • The Company intends to initiate a limited launch in several sites in U.S. when commercial product is available.
  • Shares are up 24% premarket.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.